Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Insulin Aspart”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT04698018
What this trial is testing

A Research Study to Look at How Faster Aspart Works in Chinese People With Type 1 Diabetes or Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Novo Nordisk A/S 23
Post-approval studies (Phase 4)Study completedNCT02449603
What this trial is testing

Comparison of Exenatide vs. Biphasic Insulin Aspart 30 on Glucose Variability in Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Mellitus
Xijing Hospital 150
Post-approval studies (Phase 4)Study completedNCT00788840
What this trial is testing

Detemir Energy Expenditure Study

Who this might be right for
Type 2 Diabetes MellitusObesity
University of Surrey 30
Large-scale testing (Phase 3)Study completedNCT00184574
What this trial is testing

Comparison of Biphasic Insulin Aspart 70/30, 50/50, and 30/70 in Subjects With Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 603
Not applicableStudy completedNCT04042441
What this trial is testing

A Research Study, Looking at How Ryzodeg® (Insulin Degludec/Insulin Aspart) Works in People With Type 2 Diabetes in Local Clinical Practice

Who this might be right for
Diabetes Mellitus, Type 2
Novo Nordisk A/S 1,122
Large-scale testing (Phase 3)Ended earlyNCT00523042
What this trial is testing

Safety of Inhaled Preprandial Human Insulin in Subjects With Diabetes and Asthma

Who this might be right for
DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2+1 more
Novo Nordisk A/S 10
Not applicableStudy completedNCT03212950
What this trial is testing

Closed-Loop With Faster Aspart in Young Adults With Type 1 Diabetes

Who this might be right for
Type 1 Diabetes Mellitus
University of Ljubljana, Faculty of Medicine 20
Post-approval studies (Phase 4)Study completedNCT00593255
What this trial is testing

Efficacy and Safety of Insulin Aspart in Subjects With Type 1 or Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Novo Nordisk A/S 220
Large-scale testing (Phase 3)Study completedNCT01707134
What this trial is testing

Safety and Efficacy of Insulin Aspart in Subjects With Type 1 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 1
Novo Nordisk A/S 753
Large-scale testing (Phase 3)Study completedNCT00071448
What this trial is testing

Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population

Who this might be right for
DiabetesDiabetes Mellitus, Type 1
Novo Nordisk A/S 378
Not applicableStudy completedNCT01487421
What this trial is testing

An Observational Study of Insulin Aspart and, if Necessary, Insulin Levemir (FlexPen®) in the Evening or at Bedtime

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 2,134
Large-scale testing (Phase 3)Study completedNCT01074268
What this trial is testing

Comparison of NN1250 Plus Insulin Aspart With Insulin Detemir Plus Insulin Aspart in Type 1 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 1
Novo Nordisk A/S 456
Testing effectiveness (Phase 2)Study completedNCT01526980
What this trial is testing

Glycaemic Control of Biphasic Insulin Aspart 70 and 30 in Subjects With Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 31
Large-scale testing (Phase 3)Study completedNCT00605020
What this trial is testing

Efficacy and Safety of Insulin Detemir in Combination With Insulin Aspart and Biphasic Insulin Aspart 30 in Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 719
Post-approval studies (Phase 4)Study completedNCT00494988
What this trial is testing

Self-control Trial to Evaluate the Remission Rate in Newly Diagnosed Type 2 Diabetes Patients After Treatment With Insulin Aspart

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 33
Large-scale testing (Phase 3)Study completedNCT04848480
What this trial is testing

A Research Study to Compare a New Weekly Insulin, Insulin Icodec, and an Available Daily Insulin, Insulin Degludec, Both in Combination With Mealtime Insulin in People With Type 1 Diabetes (ONWARDS 6)

Who this might be right for
Diabetes Mellitus, Type 1
Novo Nordisk A/S 582
Early research (Phase 1)Study completedNCT01523041
What this trial is testing

Comparison of Two Formulations of Biphasic Insulin Aspart 70

Who this might be right for
DiabetesHealthy
Novo Nordisk A/S 24
Post-approval studies (Phase 4)UnknownNCT00145353
What this trial is testing

Insulin NovoRapid Versus Actrapid in Treatment of Type 1 Diabetic Patients During Daily Adjustment of Insulin Dose

Who this might be right for
Type 1 Diabetes Mellitus
Odense University Hospital 16
Large-scale testing (Phase 3)Study completedNCT03387787
What this trial is testing

Evaluation of Glycaemic Control Using GlucoTab® With Insulin Degludec in Hospitalized Patients With Diabetes Mellitus Type 2

Who this might be right for
Type 2 Diabetes Mellitus
Insel Gruppe AG, University Hospital Bern 15
Post-approval studies (Phase 4)Study completedNCT00467649
What this trial is testing

Characterize Regimens of Basal Insulin Intensified With Either Symlin® or Rapid Acting Insulin in Patients With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Mellitus
AstraZeneca 112
Next Page